They took out a $1M loan to pay for it. It did not impact the overall profit, other than thr extra revenue and profit. Imagine how it would have looked without the extra 200k profit.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025